Search Results - "Scott, MD"

Cardiovascular Drug Development by Fordyce, Christopher B., MD, MSc, Roe, Matthew T., MD, MHS, Ahmad, Tariq, MD, MPH, Libby, Peter, MD, Borer, Jeffrey S., MD, Hiatt, William R., MD, Bristow, Michael R., MD, PhD, Packer, Milton, MD, Wasserman, Scott M., MD, Braunstein, Ned, MD, Pitt, Bertram, MD, DeMets, David L., PhD, Cooper-Arnold, Katharine, MPH, Armstrong, Paul W., MD, Berkowitz, Scott D., MD, Scott, Rob, MD, Prats, Jayne, PhD, Galis, Zorina S., PhD, Stockbridge, Norman, MD, PhD, Peterson, Eric D., MD, MPH, Califf, Robert M., MD

“…Abstract Despite the global burden of cardiovascular disease, investment in cardiovascular drug development has stagnated over the past 2 decades, with…”
Get full text

The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis by Stanifer, John W, Dr, Jing, Bocheng, BS, Tolan, Scott, MD, Helmke, Nicole, BS, Mukerjee, Romita, MD, Naicker, Saraladevi, Prof, Patel, Uptal, MD

“…Summary Background Amid rapid urbanisation, the HIV epidemic, and increasing rates of non-communicable diseases, people in sub-Saharan Africa are especially…”
Get full text

Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia by Jacobs, Victoria, NP, Woller, Scott C., MD, Stevens, Scott, MD, May, Heidi T., PhD, Bair, Tami L., RN, Anderson, Jeffrey L., MD, Crandall, Brian G., MD, Day, John D., MD, FHRS, Johanning, Katie, PharmD, Long, Yenh, PharmD, Mallender, Charles, MD, Olson, Jeffrey L., PharmD, Osborn, Jeffrey S., MD, Weiss, J. Peter, MD, Bunch, T. Jared, MD

“…Background The mechanisms behind the association of atrial fibrillation (AF) and dementia are unknown. One possibility is that exposure to chronic…”
Get full text

Alloplastic reconstruction of the microtic ear by Owen, Scott, MD, Wang, Tom, MD, Stephan, Scott, MD

“…Alloplast microtia repair offers many advantages over autologous costal cartilage as a framework. Advantages include earlier reconstruction, fewer procedures,…”
Get full text

Transarterial Embolization of Symptomatic Focal Nodular Hyperplasia by Birn, Jeff, MD, Williams, Todd R., MD, Croteau, Daniel, MD, Schwartz, Scott, MD, Sturza, Scott, MD, Getzen, Todd, MD

“…Abstract Purpose To evaluate the effectiveness of small size trisacryl gelatin microsphere embolization as a minimally invasive treatment option for patients…”
Get full text

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial by Raal, Frederick J, Prof, Honarpour, Narimon, MD, Blom, Dirk J, MD, Hovingh, G Kees, MD, Xu, Feng, MS, Scott, Rob, MD, Wasserman, Scott M, MD, Stein, Evan A, Prof

“…Summary Background Homozygous familial hypercholesterolaemia is a rare, serious disorder caused by very low or absent plasma clearance of LDL, substantially…”
Get full text

RadPath by Arnold, Corey W., PhD, Wallace, W. Dean, MD, Chen, Shawn, MS, Oh, Andrea, MD, Abtin, Fereidoun, MD, Genshaft, Scott, MD, Binder, Scott, MD, Aberle, Denise, MD, Enzmann, Dieter, MD

“…Rationale and Objectives The current paradigm of cancer diagnosis involves uncoordinated communication of findings from radiology and pathology to downstream…”
Get full text

Management of immune dysfunction after adult cardiac surgery by Rankin, J. Scott, MD, Oguntolu, Olusola, MD, Binford, Robert S., MD, Trochtenberg, D. Scott, MD, Muhlbaier, Lawrence H., PhD, Stratton, Charles W., MD

“…Objective Pulmonary dysfunction/multiorgan failure syndrome is an important cause of mortality and morbidity after cardiac operations. In this series, results…”
Get full text

Huge traumatic pulmonary artery pseudoaneurysm by Shnayderman, Dmitriy, MD, Baginski, Scott G., MD, Lea, William B., MD, Erickson, Scott J., MD

“…Abstract Pulmonary artery pseudoaneurysm is a very rare complication of penetrating thoracic trauma. We present a case of a 27-year-old woman who developed a…”
Get full text

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study by Hellmann, Matthew D, Dr, Rizvi, Naiyer A, Prof, Goldman, Jonathan W, MD, Gettinger, Scott N, MD, Borghaei, Hossein, DO, Brahmer, Julie R, MD, Ready, Neal E, Prof, Gerber, David E, MD, Chow, Laura Q, MD, Juergens, Rosalyn A, MD, Shepherd, Frances A, Prof, Laurie, Scott A, MD, Geese, William J, PhD, Agrawal, Shruti, PhD, Young, Tina C, MS, Li, Xuemei, MD, Antonia, Scott J, Prof

“…Summary Background Nivolumab has shown improved survival in the treatment of advanced non-small-cell lung cancer (NSCLC) previously treated with chemotherapy…”
Get full text

Medial Femoral Condyle Microvascular Bone Transfer as a Treatment for Capitate Avascular Necrosis: Surgical Technique and Case Report by Kazmers, Nikolas H., MD, MSE, Rozell, Joshua C., MD, Rumball, Kevin M., MD, Kozin, Scott H., MD, Zlotolow, Dan A., MD, Levin, L. Scott, MD

“…Avascular necrosis (AVN) of the capitate is a rare clinical entity for which a variety of treatment options have been described, ranging from immobilization to…”
Get full text

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance by Stroes, Erik, MD, PhD, Colquhoun, David, MD, Sullivan, David, MD, Civeira, Fernando, MD, Rosenson, Robert S., MD, Watts, Gerald F., DSc, PhD, DM, Bruckert, Eric, MD, Cho, Leslie, MD, Dent, Ricardo, MD, Knusel, Beat, PhD, Xue, Allen, PhD, Scott, Rob, MD, Wasserman, Scott M., MD, Rocco, Michael, MD

“…Objectives This study sought to evaluate the efficacy and safety of subcutaneous evolocumab compared with oral ezetimibe in hypercholesterolemic patients who…”
Get full text

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study by Koren, Michael J, Dr, Scott, Rob, MD, Kim, Jae B, MD, Knusel, Beat, PhD, Liu, Thomas, PhD, Lei, Lei, PhD, Bolognese, Michael, MD, Wasserman, Scott M, MD

“…Summary Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) increases serum LDL-cholesterol (LDL-C) concentrations. We assessed the effects of AMG…”
Get full text

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial by Raal, Frederick J, Prof, Stein, Evan A, Prof, Dufour, Robert, MD, Turner, Traci, MD, Civeira, Fernando, MD, Burgess, Lesley, Prof, Langslet, Gisle, MD, Scott, Russell, Prof, Olsson, Anders G, Prof, Sullivan, David, MD, Hovingh, G Kees, MD, Cariou, Bertrand, MD, Gouni-Berthold, Ioanna, MD, Somaratne, Ransi, MD, Bridges, Ian, MSc, Scott, Rob, MD, Wasserman, Scott M, MD, Gaudet, Daniel, Prof

“…Summary Background Heterozygous familial hypercholesterolaemia is characterised by low cellular uptake of LDL cholesterol, increased plasma LDL cholesterol…”
Get full text

Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial by Sabatine, Marc S., MD, MPH, Giugliano, Robert P., MD, SM, Keech, Anthony, MD, Honarpour, Narimon, MD, PhD, Wang, Huei, PhD, Liu, Thomas, PhD, Wasserman, Scott M., MD, Scott, Robert, MD, Sever, Peter S., MD, Pedersen, Terje R., MD

“…Background Despite current therapies, patients with vascular disease remain at high risk for major adverse cardiovascular events. Low-density lipoprotein…”
Get full text

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study by Giugliano, Robert P, Dr, Desai, Nihar R, MD, Kohli, Payal, MD, Rogers, William J, Prof, Somaratne, Ransi, MD, Huang, Fannie, MS, Liu, Thomas, PhD, Mohanavelu, Satishkumar, MS, Hoffman, Elaine B, PhD, McDonald, Shannon T, BSN, Abrahamsen, Timothy E, BA, Wasserman, Scott M, MD, Scott, Robert, MD, Sabatine, Marc S, MD

“…Summary Background LDL cholesterol (LDL-C) is a well established risk factor for cardiovascular disease. Proprotein convertase subtilisin/kexin type 9 (PCSK9)…”
Get full text

Risk of Bleeding after Native Renal Biopsy as a Function of Preprocedural Systolic and Diastolic Blood Pressure by Kriegshauser, J. Scott, MD, Patel, Maitray D., MD, Young, Scott W., MD, Chen, Frederick, MD, Eversman, William G., MD, Chang, Yu-Hui H., PhD

“…Abstract Purpose To determine the risk of bleeding complications after native renal biopsy as a function of preprocedural blood pressure (BP). Materials and…”
Get full text

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145) by Raal, Frederick J., MB BCh, MMed, PhD, Giugliano, Robert P., MD, SM, Sabatine, Marc S., MD, MPH, Koren, Michael J., MD, Langslet, Gisle, MD, Bays, Harold, MD, Blom, Dirk, PhD, MD, Eriksson, Mats, MD, Dent, Ricardo, MD, Wasserman, Scott M., MD, Huang, Fannie, MS, Xue, Allen, PhD, Albizem, Moetaz, MD, Scott, Rob, MD, Stein, Evan A., MD, PhD

“…Objectives The purpose of this study was assess the effect of evolocumab (AMG 145) on lipoprotein (Lp)(a) from a pooled analysis of 4 phase II trials…”
Get full text

Distal Ulnar Hounsfield Units Accurately Predict Bone Mineral Density and Future Fragility Fracture Risk by Wagner, Scott, MD, Dworak, Theodora Catherine, MD, Grimm, Patrick, MD, Balazs, George C., MD, Tintle, Scott M., MD

Get full text

What Happens to Serum Metal Ion Levels After a Metal-on-Metal Bearing is Removed? by Ball, Scott T., MD, Severns, Dustyn, PA-C, Linn, Michael, MD, Meyer, R. Scott, MD, Swenson, F. Craig, MD

“…Abstract Serum cobalt (Co) and chromium (Cr) levels are commonly used to screen for excessive wear of metal-on-metal hip replacements. However, it is unknown…”
Get full text